Related Experiment Video
Updated: Aug 14, 2025
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
The Appropriately Designed TDM Clinical Trial: Endpoints, Pitfalls, and Perspectives
1Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Therapeutic Drug Monitoring
|January 10, 2023
Summary
Designing effective clinical trials for therapeutic drug monitoring (TDM) is crucial. Lessons from past successes and failures can guide future TDM study designs for better implementation.
Area of Science:
- Pharmacology
- Clinical Trials
- Drug Monitoring
Background:
- Clinical trials are essential for validating therapeutic drug monitoring (TDM).
- Past TDM studies show both significant successes and notable failures.
- Experience from previous trials informs future research design.
Purpose of the Study:
- To provide evidence for the broad implementation of therapeutic drug monitoring (TDM).
- To guide the design and conduct of future TDM studies.
- To share lessons learned from past TDM research.
Main Methods:
- Review of personal experience and published literature on TDM studies.
- Analysis of factors influencing the success and failure of TDM trials.
- Development of recommendations for study design and conduct.
Main Results:
- Identification of key elements for successful TDM study design.
- Recommendations to minimize protocol deviations.
- Strategies to enhance the clinical impact of TDM studies.
Conclusions:
- Past TDM study experiences offer valuable lessons.
- This article outlines potential TDM study designs, endpoints, and challenges.
- Learning from prior research is vital for advancing TDM implementation.
Related Concept Videos
01:11Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
156
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
156
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:12Hazard Ratio
200
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
200